NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis

Sotirios Tsimikas, Sergio Fazio, Keith C. Ferdinand, Henry N. Ginsberg, Marlys L. Koschinsky, Santica M. Marcovina, Patrick M. Moriarty, Daniel J. Rader, Alan T. Remaley, Gissette Reyes-Soffer, Raul D. Santos, George Thanassoulis, Joseph L. Witztum, Simhan Danthi, Michelle Olive, Lijuan Liu

    Research output: Contribution to journalReview article

    95 Scopus citations

    Abstract

    Pathophysiological, epidemiological, and genetic studies provide strong evidence that lipoprotein(a) [Lp(a)] is a causal mediator of cardiovascular disease (CVD) and calcific aortic valve disease (CAVD). Specific therapies to address Lp(a)-mediated CVD and CAVD are in clinical development. Due to knowledge gaps, the National Heart, Lung, and Blood Institute organized a working group that identified challenges in fully understanding the role of Lp(a) in CVD/CAVD. These included the lack of research funding, inadequate experimental models, lack of globally standardized Lp(a) assays, and inadequate understanding of the mechanisms underlying current drug therapies on Lp(a) levels. Specific recommendations were provided to facilitate basic, mechanistic, preclinical, and clinical research on Lp(a); foster collaborative research and resource sharing; leverage expertise of different groups and centers with complementary skills; and use existing National Heart, Lung, and Blood Institute resources. Concerted efforts to understand Lp(a) pathophysiology, together with diagnostic and therapeutic advances, are required to reduce Lp(a)-mediated risk of CVD and CAVD.

    Original languageEnglish (US)
    Pages (from-to)177-192
    Number of pages16
    JournalJournal of the American College of Cardiology
    Volume71
    Issue number2
    DOIs
    StatePublished - Jan 16 2018

    Keywords

    • aortic stenosis
    • cardiovascular disease
    • lipoprotein(a)
    • metabolism
    • pathophysiology
    • therapy

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Fingerprint Dive into the research topics of 'NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis'. Together they form a unique fingerprint.

  • Cite this

    Tsimikas, S., Fazio, S., Ferdinand, K. C., Ginsberg, H. N., Koschinsky, M. L., Marcovina, S. M., Moriarty, P. M., Rader, D. J., Remaley, A. T., Reyes-Soffer, G., Santos, R. D., Thanassoulis, G., Witztum, J. L., Danthi, S., Olive, M., & Liu, L. (2018). NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis. Journal of the American College of Cardiology, 71(2), 177-192. https://doi.org/10.1016/j.jacc.2017.11.014